SERUM LEVELS OF BUTORPHANOL BY RADIOIMMUNOASSAY

被引:29
作者
PITTMAN, KA
SMYTH, RD
MAYOL, RF
机构
关键词
D O I
10.1002/jps.2600690211
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:160 / 163
页数:4
相关论文
共 18 条
[1]  
ACKERMAN E, 1969, BIOMATHEMATICS, V1, P139
[2]   PLASMA AND CEREBROSPINAL-FLUID CONCENTRATIONS OF PENTAZOCINE IN PATIENTS - ASSAY BY MASS FRAGMENTOGRAPHY [J].
AGURELL, S ;
BOREUS, LO ;
GORDON, E ;
LINDGREN, JE ;
EHRNEBO, M ;
LONROTH, U .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1974, 26 (01) :1-8
[3]   ABSORPTION, BLOOD CONCENTRATIONS AND EXCRETION OF PENTAZOCINE AFTER ORAL, INTRAMUSCULAR OR RECTAL ADMINISTRATION TO MAN [J].
BECKETT, AH ;
KOUROUNAKIS, P ;
VAUGHAN, DP ;
MITCHARD, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1970, 22 :S169-+
[4]  
BERKOWITZ BA, 1975, CLIN PHARMACOL THER, V17, P629
[5]   RELATION BETWEEN MORPHINE PHARMACOKINETICS AND ANALGESIA [J].
DAHLSTROM, BE ;
PAALZOW, LK ;
SEGRE, G ;
AGREN, AJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (01) :41-53
[6]  
DOBKIN AB, 1975, CLIN PHARMACOL THER, V18, P547
[7]  
EHRNEBO M, 1977, CLIN PHARMACOL THER, V22, P888
[8]  
FINDLAY JWA, 1977, CLIN PHARMACOL THER, V22, P439
[9]  
GILBERT MS, 1976, CLIN PHARMACOL THER, V20, P359
[10]  
HATCH KF, 1976, CLIN CHEM, V22, P1383